P00747 (PLMN_HUMAN) Homo sapiens (Human)
Plasminogen UniProtKBInterProSTRINGInteractive Modelling
810 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
47 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE |
Heteromer P00779; | |||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF MICROPLASMINOGEN-STREPTOKINASE ALPHA DOMAIN COMPLEX |
Heteromer P00779; | 2×SO4; | ||||
| Assess | ||||||
| Structure of the ternary microplasmin-staphylokinase-microplasmin complex: a proteinase-cofactor-su… |
Heteromer P15240; | 1×0GJ; | ||||
| Assess | ||||||
| Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold … |
Heteromer Q4GWU5; | 2×SO4; | ||||
| Assess | ||||||
| X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF MICROPLASMINOGEN WITH ALPHA DOMAIN OF STREPTOKINASE IN TH… |
Heteromer P00779; | 6×CD; | ||||
| Assess | ||||||
| Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold … |
Heteromer Q4GWU5; | 1×SO4; 2×GOL; | ||||
| Assess | ||||||
| Crystal structure of human microplasmin in complex with kazal-type inhibitor AaTI |
Heteromer A0A1S4FCI9; | 1×GOL; 3×NA; | ||||
| Assess | ||||||
| Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold … |
Heteromer Q4GWU5; | |||||
| Assess | ||||||
| Protease SFTI complex |
Heteromer Q4GWU5; | |||||
| Assess | ||||||
| Structure of plasmin and peptide complex |
Heteromer Q4GWU5; | 1×WMH; | ||||
| Assess | ||||||
| Crystal structure of the plasmin-textilinin-1 complex |
Heteromer Q90WA1; | |||||
| Assess | ||||||
| The X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound to a peptide… |
Heteromer P49054; | |||||
| Assess | ||||||
| The X-ray crystallographic structure of the angiogenesis inhibitor, angiostatin, bound a to a pepti… |
Heteromer P49054; | 1×DIO; | ||||
| Assess | ||||||
| SOLUTION STRUCTURE OF THE COMPLEX OF MUTANT VEK50[RH1/AA] AND PLASMINOGEN KRINGLE 2 |
Heteromer P49054; | |||||
| Assess | ||||||
| SOLUTION STRUCTURE OF THE COMPLEX OF MUTANT VEK50[RH2/AA] AND PLASMINOGEN KRINGLE 2 |
Heteromer P49054; | |||||
| Assess | ||||||
| plasminogen binding group A streptococcal M protein |
Heteromer P49054; | 2×SO4; | ||||
| Assess | ||||||
| STRUCTURE AND BINDING DETERMINANTS OF THE RECOMBINANT KRINGLE-2 DOMAIN OF HUMAN PLASMINOGEN TO AN I… |
Heteromer P49054; | |||||
| Assess | ||||||
| Solution structure of AGL55-Kringle 2 complex |
Heteromer M4I022; | |||||
| Assess | ||||||
| Solution structure of KTI55-Kringle 2 complex |
Heteromer M4I070; | |||||
| Assess | ||||||
| Y. pestis Plasminogen Activator Pla in Complex with Human Plasminogen Activation Loop Peptide ALP11 |
Heteromer P17811; | 4×MRD; 2×MPD; 1×C8E; 1×PO4; | ||||
| Assess | ||||||
| STRUCTURE AND LIGAND DETERMINANTS OF THE RECOMBINANT KRINGLE 5 DOMAIN OF HUMAN PLASMINOGEN | homo-2-mer | |||||
| Assess | ||||||
| STRUCTURAL BASIS FOR THE CONFORMATIONAL MODULATION | monomer | 1×NGA; 2×CL; | ||||
| Assess | ||||||
| The X-ray Crystal Structure of Full-Length type II Human Plasminogen | monomer | 1×NAG; 4×CL; 1×K; 1×BCT; 1×ACT; | ||||
| Assess | ||||||
| The X-ray Crystal Structure of Full-Length type I Human Plasminogen | monomer | |||||
| Assess | ||||||
| The X-ray Structure of Human Angiostatin | monomer | 3×BCN; | ||||
| Assess | ||||||
| Protease Inhibitor | monomer | 1×89M; | ||||
| Assess | ||||||
| Protease Inhibitor | monomer | 1×89S; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN PLASMINOGEN CATALYTIC DOMAIN | monomer | |||||
| Assess | ||||||
| Human PLASMINOGEN CATALYTIC DOMAIN, K698M MUTANT | monomer | 8×SO4; | ||||
| Assess | ||||||
| CATALYTIC DOMAIN OF PLASMINOGEN | monomer | |||||
| Assess | ||||||
| Macrocyclic Plasmin Inhibitor | monomer | 1×GGI; 2×SO4; | ||||
| Assess | ||||||
| Macrocyclic plasmin inhibitor | monomer | 1×M63; 1×SO4; | ||||
| Assess | ||||||
| Macrocyclic plasmin inhibitor | monomer | 1×EUA; 3×SO4; | ||||
| Assess | ||||||
| Macrocyclic plasmin inhibitor | monomer | 1×I5Y; 4×SO4; | ||||
| Assess | ||||||
| Solution structure and functional characterization of human plasminogen kringle 5 | monomer | |||||
| Assess | ||||||
| Solution Structure of Human Plasminogen Kringle 3 | monomer | |||||
| Assess | ||||||
| KRINGLE 2 DOMAIN OF HUMAN PLASMINOGEN: NMR SOLUTION STRUCTURE OF TRANS-4-AMINOMETHYLCYCLOHEXANE-1-C… | monomer | 1×AMH; | ||||
| Assess | ||||||
| plasminogen kringle 1 in complex with inhibitor | monomer | 1×XO3; | ||||
| Assess | ||||||
| THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WITH… | monomer | 1×ACA; | ||||
| Assess | ||||||
| THE STRUCTURE OF THE NON-COVALENT COMPLEX OF RECOMBINANT KRINGLE 1 DOMAIN OF HUMAN PLASMINOGEN WITH… | monomer | 1×AMH; | ||||
| Assess | ||||||
| THE REFINED STRUCTURE OF THE EPSILON-AMINOCAPROIC ACID COMPLEX OF HUMAN PLASMINOGEN KRINGLE | monomer | 1×ACA; | ||||
| Assess | ||||||
| THE STRUCTURE OF RECOMBINANT PLASMINOGEN KRINGLE 1 AND THE FIBRIN BINDING SITE | monomer | 2×CL; | ||||
| Assess | ||||||
| STRUCTURE OF KRINGLE 4 AT 4C TEMPERATURE AND 1.67 ANGSTROMS RESOLUTION | monomer | 1×SO4; | ||||
| Assess | ||||||
| CRYSTAL AND MOLECULAR STRUCTURE OF HUMAN PLASMINOGEN KRINGLE 4 REFINED AT 1.9-ANGSTROMS RESOLUTION | monomer | 1×SO4; | ||||
| Assess | ||||||
| SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC ACI… | monomer | |||||
| Assess | ||||||
| SOLUTION NMR STRUCTURE OF THE HUMAN PLASMINOGEN KRINGLE 1 DOMAIN COMPLEXED WITH 6-AMINOHEXANOIC ACI… | monomer | 1×ACA; | ||||
| Assess | ||||||
| KRINGLE-KRINGLE INTERACTIONS IN MULTIMER KRINGLE STRUCTURES | monomer | |||||
| Assess | ||||||
8 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 4dur.2.A | monomer | 0.79 | 1×K; | 100.00 | ||
| Assess | ||||||
| 5edm.1.A | monomer | 0.64 | 36.12 | |||
| Assess | ||||||
| 4hzh.2.A | monomer | 0.58 | 35.33 | |||
| Assess | ||||||
| 5edm.1.A | monomer | 0.58 | 37.56 | |||
| Assess | ||||||
| 4nzq.1.A | monomer | 0.57 | 38.02 | |||
| Assess | ||||||
| 5edk.1.A | monomer | 0.56 | 38.02 | |||
| Assess | ||||||
| 6c2w.1.A | monomer | 0.54 | 35.65 | |||
| Assess | ||||||
| 6c2w.1.A | monomer | 0.51 | 37.06 | |||
| Assess | ||||||